QIAGEN powered by
Prioritize biologically- and clinically-relevant mutations in your NGS cancer data

QIAGEN Digital Insights Monday, August 15, 2022

Many labs struggle with prioritizing clinically- and biologically-relevant variants among the millions of variants detected using NGS. Labs are starting…

Together, let’s unlock the biological discoveries hidden in single cells

QIAGEN Digital Insights Wednesday, July 13, 2022

Explore an easy way to extend your in-house resources to include integrated single-cell data and analysis Single-cell sequencing is a…

New Content Release: HGMD Professional 2022.2

QIAGEN Digital Insights Friday, July 1, 2022

More mutations, better annotations, confident classifications HGMD Professional 2022.2 is now available, expanding the world’s largest collection of human inherited…

Take the legwork out of drug toxicity screening

QIAGEN Digital Insights Tuesday, June 7, 2022

How to easily create, manage and share adverse outcome pathways to accelerate drug discovery programs Scientists working in drug discovery…

Avoid the ‘omics data odyssey with a helping hand

QIAGEN Digital Insights Thursday, June 2, 2022

Do you spend hours cleaning up and integrating ‘omics data, yet still feel like you are drowning in it? ‘Omics…

Know your biomarkers: How PRKD1 is linked to head and neck squamous cell carcinoma (HNSCC)

QIAGEN Digital Insights Tuesday, May 31, 2022

COSMIC v96 adds new oncogene that may be beneficial to diagnose HNSCC Head and neck cancers are a heterogeneous collection…

Scale your exome workflow with Dr. Atil Bisgin at ESHG 2022

QIAGEN Digital Insights Thursday, May 19, 2022

Have you reserved your in-person or virtual spot at the European Human Genetics Conference (ESHG) held June 11-14, 2022, in…

How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability

QIAGEN Digital Insights Monday, April 25, 2022

The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into the trove…

Accelerate your data science-driven drug discovery: Announcing QIAGEN Biomedical Knowledge Base

QIAGEN Digital Insights Monday, April 25, 2022

You need biomedical relationships knowledge for innovative data- and analytics-driven drug discovery. Yet this knowledge is locked in thousands of…

New Content Release: HGMD Professional 2022.1

QIAGEN Digital Insights Tuesday, March 29, 2022

More mutations, better annotations, confident classifications HGMD Professional 2022.1 is now available, expanding the world’s largest collection of human inherited disease…

Using knowledge graphs to drive drug discovery

QIAGEN Digital Insights Tuesday, March 29, 2022

Have you ever done a Google search to find a restaurant or look up what your favorite actor is up…

3 trends that promise to quietly revolutionize cancer research and diagnostics in 2022

QIAGEN Digital Insights Friday, March 4, 2022

Experts forecast this year’s cancer research advances In cancer research, the focus has shifted to precision medicine and much progress…